The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase III, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer (BOLERO-3).
Ruth O'Regan
Consultant or Advisory Role - Novartis
Research Funding - Genentech; Novartis
Mustafa Ozguroglu
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Fabrice Andre
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Masakazu Toi
Honoraria - Novartis
Research Funding - Novartis
Guy Heinrich Maria Jerusalem
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis
Sharon Wilks
Honoraria - Novartis
Claudine Isaacs
Consultant or Advisory Role - AstraZeneca; Celgene; Enzon; Genentech
Binghe Xu
No relevant relationships to disclose
Norikazu Masuda
No relevant relationships to disclose
Francis P. Arena
Research Funding - Novartis
Denise Aysel Yardley
Consultant or Advisory Role - Novartis
Yoon Sim Yap
Honoraria - Novartis
Pabak Mukhopadhyay
Employment or Leadership Position - Novartis
Shyanne Douma
Employment or Leadership Position - Novartis
Mona El-Hashimy
Employment or Leadership Position - Novartis
Tanya Taran
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Tarek Sahmoud
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
David Edward Lebwohl
Employment or Leadership Position - Novartis
Luca Gianni
Consultant or Advisory Role - AstraZeneca; BioScience; Boehringer Ingelheim; Celgene; Genentech; GlaxoSmithKline; Novartis; Pfizer; Roche; Taiho Pharmaceutical